Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
FUJIFILM Corporation has announced a $188 million investment to establish a cell culture media manufacturing […]
First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy
Telix Pharmaceuticals has announced that a first patient has been dosed in a Phase II […]
ViroCell Strengthens Senior Management Team with Appointment of Nick Maishman as COO
ViroCell Biologics, founded by the UK’s most prolific academic viral vector manufacturing team, today announces […]
FUJIFILM Healthcare Europe partners with The Royal College of Surgeons of Edinburgh
FUJIFILM Healthcare Europe, a leading provider of medical imaging solutions, has become an organisational partner […]
EmbarkNeuro Announces Initiation of Phase 2 Trial of ANC-501 for the Personalized Treatment of Depression (MDD)
EmbarkNeuro, a neuroscience-focused biotech company formerly known as Ancora Bio that was founded in 2021 […]
Vial Has Added NEXT Oncology, a Global Network of Phase I Cancer Research Centers, to their Preferred Site Network
Vial has added NEXT Oncology to their Preferred Site Network (PSN). Founded by renowned oncologist Dr. Anthony W. […]
Dr. Cheryl Pegus, Former Walmart EVP of Health & Wellness, Joins Morgan Health
Dr. Cheryl Pegus, a nationally-recognized leader for her work to deliver affordable, high-quality care to millions of […]
CellVax Selects Theragent as Manufacturing Partner for Phase 2 Clinical Trial for Prostate Cancer Immunotherapy
Theragent, a cell therapy Contract Development and Manufacturing Organization (CDMO) focused on advancing next-generation cancer […]
Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer
Quell Therapeutics Ltd, a world leader in developing engineered T-regulatory (Treg) cell therapies for serious […]
MUSC Health Selects UpStream Healthcare as its Value-Based Partner for Medicare Patients
The Medical University of South Carolina (MUSC Health) and national value-based healthcare company, UpStream Healthcare, have […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more